Lataa...

Enhancing poxvirus vectors vaccine immunogenicity

Attenuated recombinant poxvirus vectors expressing heterologous antigens from pathogens are currently at various stages in clinical trials with the aim to establish their efficacy. This is because these vectors have shown excellent safety profiles, significant immunogenicity against foreign expresse...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: García-Arriaza, Juan, Esteban, Mariano
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896794/
https://ncbi.nlm.nih.gov/pubmed/25424927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.28974
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!